Back to mobile site

Needham Reiterates Buy Rating on RxSight Inc. (RXST)

February 26, 2026 6:09 AM EST Send to a Friend
Needham analyst David Saxon reiterated a Buy rating and $13.00 price target on RxSight Inc. (NASDAQ: RXST).The analyst commented: "RXST's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login